By mimicking the natural hormone GLP-1, these drugs help lower blood sugar levels, reduce appetite, and promote significant weight reduction
IL-17A and IL-17F are the downstream effectors that directly drive inflammation in joints and skin
The article outlines several key points in this ongoing discussion: Potential Protective Effects: Some research suggests that GLP-1 receptor agonists may offer protective effects against colorectal cancer
Correlation of the confocal slice to the corresponding TEM tomogram (Fig
Studies show that with consistent effort, most people lose 510% of their starting weight after a year of lifestyle changes alone, which can significantly improve heart health, quality of life, and reduce the risk of type 2 diabetes
What the clinical trials tell us about injection sites The landmark phase 2 trial for retatrutide, published in the New England Journal of Medicine (Jastreboff et al., 2023), enrolled 338 adults with obesity